1
|
Ufere NN, Lago-Hernandez C, Alejandro-Soto A, Walker T, Li L, Schoener K, Keegan E, Gonzalez C, Bethea E, Singh S, El-Jawahri A, Nephew L, Jones P, Serper M. Health care-related transportation insecurity is associated with adverse health outcomes among adults with chronic liver disease. Hepatol Commun 2024; 8:e0358. [PMID: 38206200 PMCID: PMC10786597 DOI: 10.1097/hc9.0000000000000358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Accepted: 11/07/2023] [Indexed: 01/12/2024] Open
Abstract
BACKGROUND Health care-related transportation insecurity (delayed or forgone medical care due to transportation barriers) is being increasingly recognized as a social risk factor affecting health outcomes. We estimated the national burden and adverse outcomes of health care-related transportation insecurity among US adults with chronic liver disease (CLD). METHODS Using the U.S. National Health Interview Survey from 2014 to 2018, we identified adults with self-reported CLD. We used complex weighted survey analysis to obtain national estimates of health care-related transportation insecurity. We examined the associations between health care-related transportation insecurity and health care-related financial insecurity, food insecurity, self-reported health status, work productivity, health care use, and mortality. RESULTS Of the 3643 (representing 5.2 million) US adults with CLD, 267 [representing 307,628 (6%; 95% CI: 5%-7%)] reported health care-related transportation insecurity. Adults with CLD experiencing health care-related transportation insecurity had 3.5 times higher odds of cost-related medication nonadherence [aOR, 3.5; (2.4-5.0)], 3.5 times higher odds of food insecurity [aOR, 3.5; (2.4-5.3)], 2.5 times higher odds of worsening self-reported health status over the past year [aOR, 2.5; (1.7-3.7)], 3.1 times higher odds of being unable to work due to poor health over the past year [aOR, 3.1; (2.0-4.9)], and 1.7 times higher odds of being in a higher-risk category group for number of hospitalizations annually [aOR, 1.7; (1.2-2.5)]. Health care-related transportation insecurity was independently associated with mortality after controlling for age, income, insurance status, comorbidity burden, financial insecurity, and food insecurity [aHR, 1.7; (1.4-2.0)]. CONCLUSIONS Health care-related transportation insecurity is a critical social risk factor that is associated with health care-related financial insecurity, food insecurity, poorer self-reported health status and work productivity, and increased health care use and mortality among US adults with CLD. Efforts to screen for and reduce health care-related transportation insecurity are warranted.
Collapse
Affiliation(s)
- Nneka N. Ufere
- Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Carlos Lago-Hernandez
- Department of Medicine, Division of Hospital Medicine, University of California San Diego, La Jolla, California, USA
| | - Alysa Alejandro-Soto
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Tiana Walker
- Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Lucinda Li
- Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Kimberly Schoener
- Department of Social Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Eileen Keegan
- Department of Social Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Carolina Gonzalez
- Department of Social Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Emily Bethea
- Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Siddharth Singh
- Department of Medicine, Division of Gastroenterology and Hepatology, University of California San Diego, La Jolla, California, USA
- Department of Medicine, Division of Biomedical Informatics, University of California San Diego, La Jolla, California, USA
| | - Areej El-Jawahri
- Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Lauren Nephew
- Division of Gastroenterology & Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Patricia Jones
- Department of Medicine, Division of Digestive Health and Liver Services, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Marina Serper
- Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| |
Collapse
|
2
|
Ayele R, Macchi ZA, Dini M, Bock M, Katz M, Pantilat SZ, Jones J, Kluger BM. Experience of Community Neurologists Providing Care for Patients With Neurodegenerative Illness During the COVID-19 Pandemic. Neurology 2021; 97:e988-e995. [PMID: 34489348 PMCID: PMC8448550 DOI: 10.1212/wnl.0000000000012363] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Accepted: 06/04/2021] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE Health care delivery systems transformed rapidly at the beginning of the coronavirus disease 2019 (COVID-19) pandemic to slow the spread of the virus while identifying novel methods for providing care. In many ways, the pandemic affected both persons with neurologic illness and neurologists. This study describes the perspectives and experiences of community neurologists providing care for patients with neurodegenerative illnesses during the COVID-19 pandemic. METHODS We conducted a qualitative study with 20 community neurologists from a multisite comparative-effectiveness trial of outpatient palliative care from July 23, 2020, to November 11, 2020. Participants were interviewed individually about the impact of the coronavirus disease 2019 (COVID-19) pandemic on their professional and personal lives. Interviews were analyzed with matrix analysis to identify key themes. RESULTS Four main themes illustrated the impact of the pandemic on community neurologists: (1) challenges of the current political climate, (2) lack of support for new models of care, (3) being on the frontline of suffering, and (4) clinician self-care. Taken together, the themes capture the unusual environment in which community neurologists practice, the lack of clinician trust among some patients, patient and professional isolation, and opportunities to support quality care delivery. CONCLUSIONS The COVID-19 pandemic and pandemic politics created an environment that made care provision challenging for community neurologists. Efforts to improve care delivery should proactively work to reduce clinician burnout while incorporating support for new models of care adopted due to the pandemic. TRIAL REGISTRATION INFORMATION ClinicalTrials.gov identifier: NCT03076671.
Collapse
Affiliation(s)
- Roman Ayele
- From the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY.
| | - Zachary A Macchi
- From the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY
| | - Megan Dini
- From the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY
| | - Meredith Bock
- From the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY
| | - Maya Katz
- From the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY
| | - Steven Z Pantilat
- From the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY
| | - Jacqueline Jones
- From the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY
| | - Benzi M Kluger
- From the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY
| |
Collapse
|